ISSN:
1432-1076
Keywords:
Screening
;
Neonatal mass screening
;
Metabolic disorders
;
Hypothyroidism
;
Hyperphenylalaninaemia
;
Galactosaemia
;
Maple syrup urine disease
;
Adrenogenital syndrome
;
Cystic fibrosis
;
Duchenne's muscular dystrophy
;
Histidinaemia
;
Hypermethioninaemia
;
Tyrosinaemia
;
Haemoglobinopathies
;
Glucose-6-phosphate dehydrogenase deficiency
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract The present situation of neonatal mass screening for metabolic disorders in eleven European countries is presented. The only disease screened for on a population wide basis in almost all countries is phenylketonuria. Screening for congenital hypothyroidism has been started in most countries or is under active consideration. A priority list of disorders that should be screened for routinely in all newborns comprises congenital hypothyroidism, hyperphenylalaninaemia, galactosaemia and maple syrup urine disease. Other disorders, like adrenogenital syndrome, cystic fibrosis. Duchenne's muscular dystrophy, histidinaemia, or tyrosinaemia cannot be recommended for mass screening at present because of an unsatisfactory test procedure or lack of effective treatment.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF00441305
Permalink
